As of May 6, 2020, nearly 3· 7 million people have been infected and around 260 000 people
have died from coronavirus disease 2019 (COVID-19) worldwide. 1 Almost all COVID-19-…

Rationale: There are no risk stratification tools for morbidity and mortality in bronchiectasis.
Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for …

This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent
exacerbations in many patients. There have been no previous international guidelines. The …

Background The aim of this prospective, multicenter study was to define the accuracy of
lung ultrasound (LUS) in the diagnosis of community-acquired pneumonia (CAP). Methods …

Background Severe coronavirus disease 2019 (COVID‐19) is characterized by an increased
risk of thromboembolic events, with evidence of microthrombosis in the lungs of deceased …

…Stefano Aliberti,Stefano Aliberti…Stefano Aliberti, Marta Di Pasquale, Anna Maria Zanaboni,
Roberto Cosentini, Anna Maria Brambilla, Sonia Seghezzi, Paolo Tarsia, Marco Mantero, …

Rationale: Eradication and suppression of Pseudomonas aeruginosa is a key priority in national
guidelines for bronchiectasis and is a major focus of drug development and clinical trials…

Introduction Hospitalised patients with coronavirus disease 2019 (COVID-19) as a result of
SARS-CoV-2 infection have a high mortality rate and frequently require noninvasive …

Background. An epidemiological link between respiratory infection and acute myocardial
infarction (AMI) has been suggested, and recent data indicate that there is an association …